Jeon et al. [112] reported that ISG15 functioned as a tumor suppressor in a mouse model of breast cancer by demonstrating that it promoted anchorage-dependent cell growth in response to doxorubicin treatment. This evidence concerns the gene ISG15 and breast carcinoma.